316 related articles for article (PubMed ID: 14652850)
1. Adoptive immunotherapy to increase the level of donor hematopoietic chimerism after nonmyeloablative marrow transplantation for severe canine hereditary hemolytic anemia.
Takatu A; Nash RA; Zaucha JM; Little MT; Georges GE; Sale GE; Zellmer E; Kuhr CS; Lothrop CD; Storb R
Biol Blood Marrow Transplant; 2003 Nov; 9(11):674-82. PubMed ID: 14652850
[TBL] [Abstract][Full Text] [Related]
2. Severe canine hereditary hemolytic anemia treated by nonmyeloablative marrow transplantation.
Zaucha JA; Yu C; Lothrop CD; Nash RA; Sale G; Georges G; Kiem HP; Niemeyer GP; Dufresne M; Cao Q; Storb R
Biol Blood Marrow Transplant; 2001; 7(1):14-24. PubMed ID: 11215693
[TBL] [Abstract][Full Text] [Related]
3. Dog leukocyte antigen-haploidentical stem cell allografts after anti-CD44 therapy and nonmyeloablative conditioning in a preclinical canine model.
Fukuda T; Kerbauy FR; Gooley T; Santos EB; Storb R; Sandmaier BM
Transplantation; 2006 Aug; 82(3):332-9. PubMed ID: 16906030
[TBL] [Abstract][Full Text] [Related]
4. IL-2 does not enhance the conversion to complete donor chimerism following nonmyeloablative hematopoietic cell transplantation in dogs.
Georges GE; Storb R; Maciej Zaucha J; Taranova AG; Gooley T; Nash RA
Bone Marrow Transplant; 2003 Jun; 31(11):1027-31. PubMed ID: 12774055
[TBL] [Abstract][Full Text] [Related]
5. Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation.
Georges GE; Storb R; Thompson JD; Yu C; Gooley T; Bruno B; Nash RA
Blood; 2000 May; 95(10):3262-9. PubMed ID: 10807798
[TBL] [Abstract][Full Text] [Related]
6. Failure of donor lymphocyte infusion to prevent graft rejection in dogs given DLA-identical marrow after 1 Gy of total body irradiation.
Baron F; Sandmaier BM; Zellmer E; Sorror M; Storer B; Storb R
Biol Blood Marrow Transplant; 2006 Aug; 12(8):813-7. PubMed ID: 16864051
[TBL] [Abstract][Full Text] [Related]
7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
8. Hematopoietic chimerism induces renal and skin allograft tolerance in DLA-identical dogs.
Tillson M; Niemeyer GP; Welch JA; Brawner W; Swaim SF; Rynders P; Lenz SD; Dean B; Lothrop CD
Exp Hematol; 2006 Dec; 34(12):1759-70. PubMed ID: 17157174
[TBL] [Abstract][Full Text] [Related]
9. Adoptive immunotherapy against allogeneic kidney grafts in dogs with stable hematopoietic trichimerism.
Graves SS; Hogan WJ; Kuhr C; Diaconescu R; Harkey M; Sale GE; Stone B; Georges GE; Storb R
Biol Blood Marrow Transplant; 2008 Nov; 14(11):1201-8. PubMed ID: 18940673
[TBL] [Abstract][Full Text] [Related]
10. Effects of extending the duration of postgrafting immunosuppression and substituting granulocyte-colony-stimulating factor-mobilized peripheral blood mononuclear cells for marrow in allogeneic engraftment in a nonmyeloablative canine transplantation model.
Zaucha JM; Yu C; Zellmer E; Takatu A; Junghanss C; Little MT; Storb R
Biol Blood Marrow Transplant; 2001; 7(9):513-6. PubMed ID: 11669218
[TBL] [Abstract][Full Text] [Related]
11. Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemia.
Iannone R; Casella JF; Fuchs EJ; Chen AR; Jones RJ; Woolfrey A; Amylon M; Sullivan KM; Storb RF; Walters MC
Biol Blood Marrow Transplant; 2003 Aug; 9(8):519-28. PubMed ID: 12931121
[TBL] [Abstract][Full Text] [Related]
12. Use of multigeneration-family molecular dog leukocyte antigen typing to select a hematopoietic cell transplant donor for a dog with T-cell lymphoma.
Lupu M; Sullivan EW; Westfall TE; Little MT; Weigler BJ; Moore PF; Stroup PA; Zellmer E; Kuhr C; Storb R
J Am Vet Med Assoc; 2006 Mar; 228(5):728-32. PubMed ID: 16506937
[TBL] [Abstract][Full Text] [Related]
13. Adoptive immunotherapy against kidney targets in dog-leukocyte antigen-identical mixed hematopoietic canine chimeras.
Junghanss C; Takatu A; Little MT; Maciej Zaucha J; Zellmer E; Yunusov M; Sale G; Georges GE; Storb R
Transplantation; 2003 Feb; 75(3):268-74. PubMed ID: 12589144
[TBL] [Abstract][Full Text] [Related]
14. Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant.
Storb R; Yu C; Zaucha JM; Deeg HJ; Georges G; Kiem HP; Nash RA; McSweeney PA; Wagner JL
Blood; 1999 Oct; 94(7):2523-9. PubMed ID: 10498626
[TBL] [Abstract][Full Text] [Related]
15. Renal allograft tolerance in DLA-identical and haploidentical dogs after nonmyeloablative conditioning and transient immunosuppression with cyclosporine and mycophenolate mofetil.
Niemeyer GP; Welch JA; Tillson M; Brawner W; Rynders P; Goodman S; Dufresne M; Dennis J; Lothrop CD
Transplant Proc; 2005 Dec; 37(10):4579-86. PubMed ID: 16387175
[TBL] [Abstract][Full Text] [Related]
16. Postgrafting immunosuppression with sirolimus and cyclosporine facilitates stable mixed hematopoietic chimerism in dogs given sublethal total body irradiation before marrow transplantation from DLA-identical littermates.
Hogan WJ; Little MT; Zellmer E; Friedetzky A; Diaconescu R; Gisburne S; Lee R; Kuhr C; Storb R
Biol Blood Marrow Transplant; 2003 Aug; 9(8):489-95. PubMed ID: 12931117
[TBL] [Abstract][Full Text] [Related]
17. Outpatient allografting in hematologic malignancies and nonmalignant disorders--applying lessons learned in the canine model to humans.
Maris M; Storb R
Cancer Treat Res; 2002; 110():149-75. PubMed ID: 11908197
[TBL] [Abstract][Full Text] [Related]
18. Correction of a large animal model of type I Glanzmann's thrombasthenia by nonmyeloablative bone marrow transplantation.
Niemeyer GP; Boudreaux MK; Goodman-Martin SA; Monroe CM; Wilcox DA; Lothrop CD
Exp Hematol; 2003 Dec; 31(12):1357-62. PubMed ID: 14662345
[TBL] [Abstract][Full Text] [Related]
19. Nonmyeloablative conditioning with busulfan before matched littermate bone marrow transplantation results in reversal of the disease phenotype in canine leukocyte adhesion deficiency.
Sokolic RA; Bauer TR; Gu YC; Hai M; Tuschong LM; Burkholder T; Colenda L; Bacher J; Starost MF; Hickstein DD
Biol Blood Marrow Transplant; 2005 Oct; 11(10):755-63. PubMed ID: 16182176
[TBL] [Abstract][Full Text] [Related]
20. Low Radiation Dose and Low Cell Dose Increase the Risk of Graft Rejection in a Canine Hematopoietic Stem Cell Transplantation Model.
Lange S; Steder A; Glass Ä; Killian D; Wittmann S; Machka C; Werner J; Schäfer S; Roolf C; Junghanss C
Biol Blood Marrow Transplant; 2016 Apr; 22(4):637-643. PubMed ID: 26802322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
